All In Biotech

Drug Trial Radar · NCT04707326

Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study

Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING Study.

Last checked: Nov 19, 2026Latest source record: Dec 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

2,040

Actual

Start

Nov 1, 2019

Primary completion

Nov 1, 2023

Study completion Nov 1, 2026

Sponsor

Lead sponsor
Erasmus Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Maasstad Hospital; Haaglanden Medical Centre; Catharina Ziekenhuis Eindhoven; Elisabeth-TweeSteden Ziekenhuis; Rijnstate Hospital; Admiraal de Ruyter Hospital; Spaarne Gasthuis; Medisch Spectrum Twente
First posted
Jan 13, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to determine real-life clinical efficacy of virally suppressed patienst switching to DTG/3TC compared to DTG triple drug cART controls

Conditions

  • Hiv

Interventions

  • Dolutegravir / Lamivudine PillDrug

    HIVRNA suppressed patients without documented M184V mutation in HIV RT and who are hepatitis B immune or have no risk factors for acquiring hepatitis B

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy On Treatment (OT)Time frame: 1 year
  2. Efficacy Intention to Treat (ITT)Time frame: 1 year

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Rijnstate Hospital

    Arnhem, Netherlands

  • Catharina Ziekenhuis

    Eindhoven, Netherlands

  • Medisch Spectrum Twente

    Enschede, Netherlands

  • Admiraal de Ruyter Ziekenhuis

    Goes, Netherlands

  • Spaarne Gasthuis

    Haarlem, Netherlands

  • Erasmus MC

    Rotterdam, Netherlands

  • MC Haaglanden

    Rotterdam, Netherlands

  • Maasstad Hospital

    Rotterdam, Netherlands

  • Elisabeth Tweesteden Hospital

    Tilburg, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.